Hjem › Bugspytkirtelkræft
Bugspytkirtelkræft kliniske forsøg rekrutterer i USA
248 studier for Bugspytkirtelkræft rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Houston, TX61 studier
- New York City, NY60 studier
- Boston, MA43 studier
- Nashville, TN39 studier
- Los Angeles, CA35 studier
- St. Louis, MO33 studier
- Arlington, VA33 studier
- San Antonio, TX31 studier
- Baltimore, MD31 studier
- Tampa, FL26 studier
- Philadelphia, PA26 studier
- San Diego, CA24 studier
- Durham, NC24 studier
- Atlanta, GA23 studier
- Dallas, TX22 studier
- Rochester, MN22 studier
- Washington, DC21 studier
- Seattle, WA21 studier
- Baldwin Park, CA21 studier
- Chicago, IL20 studier
- San Francisco, CA20 studier
- Queens, NY20 studier
- Jacksonville, FL20 studier
- Pittsburgh, PA20 studier
- Portland, OR19 studier
- Milwaukee, WI18 studier
- Columbus, OH18 studier
- Cleveland, OH18 studier
- Edison, NJ18 studier
- Grand Rapids, MI18 studier
- Phoenix, AZ16 studier
- New Haven, CT16 studier
- Salt Lake City, UT15 studier
- Orange, CA15 studier
- Miami, FL14 studier
- Ann Arbor, MI14 studier
- Omaha, NE14 studier
- Denver, CO13 studier
- Scottsdale, AZ13 studier
- Orlando, FL13 studier
Efter delstat
- Alabama11 studier
- Alaska4 studier
- Arizona33 studier
- Arkansas10 studier
- Californien91 studier
- Colorado26 studier
- Connecticut25 studier
- Delaware7 studier
- District of Columbia11 studier
- Florida64 studier
- Georgia26 studier
- Hawaii7 studier
- Idaho4 studier
- Illinois31 studier
- Indiana13 studier
- Iowa7 studier
- Kansas13 studier
- Kentucky13 studier
- Louisiana11 studier
- Maine3 studier
- Maryland44 studier
- Massachusetts47 studier
- Michigan38 studier
- Minnesota35 studier
- Mississippi5 studier
- Missouri39 studier
- Montana6 studier
- Nebraska14 studier
- Nevada7 studier
- New Hampshire4 studier
- New Jersey27 studier
- New Mexico6 studier
- New York68 studier
- North Carolina34 studier
- North Dakota6 studier
- Ohio45 studier
- Oklahoma12 studier
- Oregon19 studier
- Pennsylvania40 studier
- Rhode Island6 studier
- South Carolina12 studier
- South Dakota7 studier
- Tennessee44 studier
- Texas78 studier
- Utah26 studier
- Vermont3 studier
- Virginia40 studier
- Washington25 studier
- West Virginia6 studier
- Wisconsin29 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
RekruttererObservationsstudie
Alder 2 til 100 · Alle køn · Opdateret 2. okt. 2026 · NCT01950572Distance-Based Exercise to Preserve Function and Prevent Disability
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07059884A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06465069Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
RekruttererFase 1
Alder 18 til 120 · Alle køn · Opdateret 2. okt. 2026 · NCT06885697BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07226856Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07562152Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07529808Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT05372614Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
RekruttererFase 2
Alder 18 til 72 · Alle køn · Opdateret 2. okt. 2026 · NCT01174121A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06760819Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
RekruttererObservationsstudie
Alder 2 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT01915225A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06172478A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07090499Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT04751435Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT06423326The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07285044Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT02598349Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma
RekruttererObservationsstudie
Alder 18 til 80 · Alle køn · Opdateret 29. sep. 2026 · NCT07845617A Study of PHN-012 in Patients With Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07127874Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07621718Pancreatic Cancer Detection Consortium
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06388967A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07277413DESTINY-PANTUMOUR04
RekruttererObservationsstudie
Alder 18 til 130 · Alle køn · Opdateret 25. sep. 2026 · NCT07124000Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT04981119A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06989437Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.